Nebulizers for drug delivery to the lungs

Bibliography

• Daniels T, Mills N, Whitaker P. Nebuliser systems for drug delivery in cystic fibrosis. Cochrane Database Syst Rev 2013;4:CD007639
   Google Scholar
• Tuinman PR, Dixon B, Levi M, et al. Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations. Crit Care 2012;16:R70
   PubMed Web of Science ®Google Scholar
• Rouby JJ, Bouhemad B, Monsel A, et al. Aerosolized antibiotics for ventilator-associated pneumonia lessons from experimental studies. Anesthesiology 2012;117:1364-80
   PubMed Web of Science ®Google Scholar
• Boyden JY, Connor SR, Otolorin L, et al. Nebulized medications for the treatment of dyspnea: a literature review. J Aerosol Med Pulm Drug Deliv 2014. 10.1089/jamp.2014.1136
   PubMed Web of Science ®Google Scholar
• Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013;9:CD000052
   PubMedGoogle Scholar
• Siekmeier R, Scheuch G. Systemic treatment by inhalation of macromolecules - principles, problems, and examples. J Physiol Pharmacol 2008;59:53-79
   PubMed Web of Science ®Google Scholar
• Finlay WH. Pharmaceutical aerosol sprays for drug delivery to the lungs. In: Ashgriz N, editor. Hanbook of atomization and sprays: theory and applications. Springer; MA, USA: 2011. p. 899-908
   Google Scholar
• Finlay WH. The Mechanics of inhaled pharmaceutical aerosols: an introduction. Academic Press; London: 2001
   Google Scholar
• Lentz YK, Worden LR, Anchordoquy TJ, Lengsfeld CS. Effect of jet nebulization on DNA: identifying the dominant degradation mechanism and mitigation methods. J Aerosol Sci 2005;36:973-90
   Web of Science ®Google Scholar
• Hertel SP, Winter G, Friess W. Protein stability in pulmonary drug delivery via nebulization. Adv Drug Deliv Rev 2014. 10.1016/j.addr.2014.10.003
   PubMedGoogle Scholar
• Albasarah YY, Somavarapu S, Taylor KM. Stabilizing protein formulations during air-jet nebulization. Int J Pharm 2010;402:140-5
   PubMed Web of Science ®Google Scholar
• Lelong N, Vecellio L, de Gelicourt YS, et al. Comparison of numerical simulations to experiments for atomization in a jet nebulizer. PLoS One 2013;8:e78659
   Google Scholar
• Corcoran TE, Mansour A, Chigier N. Medical atomization design for inhalation therapy. American Society of Mechanical Engineers, Fluids Engineering Division (Publication) FED. Seventh Int'l Conference on Liquid Atomization (ICLASS - 97), Seoul, Korea 1997;244:255-63
   Google Scholar
• Cipolla D, Gonda I, Chan HK. Liposomal formulations for inhalation. Ther Deliv 2013;4:1047-72
   PubMedGoogle Scholar
• Kwok PCL, Trietsch SJ, Kumon M, Chan HK. Electrostatic charge characteristics of jet nebulized aerosols. J Aerosol Med Pulm Drug Deliv 2010;23:149-59
   PubMed Web of Science ®Google Scholar
• Najlah M, Parveen I, Alhnan MA, et al. The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers. Int J Pharm 2014;461:234-41
   PubMed Web of Science ®Google Scholar
• Finlay WH, Stapleton KW, Zuberbuhler P. Predicting regional lung dosages of a nebulized suspension: pulmicort (®) (budesonide). Particul Sci Technol 1997;15:243-51
   Web of Science ®Google Scholar
• Yeo LY, Friend JR, McIntosh MP, et al. Ultrasonic nebulization platforms for pulmonary drug delivery. Expert Opin Drug Deliv 2010;7:663-79
   PubMed Web of Science ®Google Scholar
• Mccallion ON, Taylor KM, Thomas M, Taylor AJ. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm Res 1995;12:1682-8
   PubMed Web of Science ®Google Scholar
• Phipps PR, Gonda I. Droplets produced by medical nebulizers - some factors affecting their size and solute concentration. Chest 1990;97:1327-32
   PubMed Web of Science ®Google Scholar
• Cipolla D, Clark AR, Chan HK, et al. Assessment of aerosol delivery systems for recombinant human deoxyribonuclease. STP Pharma Sci 1994;4:50-62
   Google Scholar
• Rajapaksa AE, Ho JJ, Qi A, et al. Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization. Respir Res 2014;15:60
   PubMed Web of Science ®Google Scholar
• Qi A, Friend JR, Yeo LY, et al. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization. Lab Chip 2009;9:2184-93
   PubMed Web of Science ®Google Scholar
• Knoch M, Keller M. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems. Expert Opin Drug Deliv 2005;2:377-90
   PubMedGoogle Scholar
• Newman S, Gee-Turner A. The omron microair vibrating mesh technology nebuliser, a 21st century approach to inhalation therapy. J Appl Ther Res 2005;5:29-33
   Google Scholar
• Ward ME, Woodhouse A, Mather LE, et al. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin Pharmacol Ther 1997;62:596-609
   PubMed Web of Science ®Google Scholar
• Zierenberg B, Eicher J, Dunne S, Freund B. Boehringer Ingelheim nebulizer BINEB a new approach to inhalation therapy. Interpharm Press; Buffalo Grove, IL: 1996. p. 187-93
   Google Scholar
• Jaeger J, Cirillo P, Eicher J, et al. Device for producing high pressure in a fluid in miniature. United States patent US69185467; 2005
   Google Scholar
• Finlay WH. Estimating the type of hygroscopic behavior exhibited by aqueous droplets. J Aerosol Med 1998;11:221-9
   PubMedGoogle Scholar
• Saleh R, Shihadeh A. Hygroscopic growth and evaporation in an aerosol with boundary heat and mass transfer. J Aerosol Sci 2007;38:1-16
   Web of Science ®Google Scholar
• Finlay WH, Stapleton KW. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Anderson impactor. J Aerosol Sci 1999;30:105-9
   Web of Science ®Google Scholar
• Dennis J, Berg E, Sandell D, et al. Cooling the NGI - an approach to size a nebulised aerosol more accurately. Pharmeur Sci Notes 2008;2008:27-30
   PubMedGoogle Scholar
• Kwong WT, Ho SL, Coates AL. Comparison of nebulized particle size distribution with malvern laser diffraction analyzer versus andersen cascade impactor and low-flow marple personal cascade impactor. J Aerosol Med 2000;13:303-14
   PubMedGoogle Scholar
• Gurses BK, Smaldone GC. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor. J Aerosol Med 2003;16:387-94
   PubMedGoogle Scholar
• Corcoran TE, Hitron R, Humphrey W, Chigier N. Optical measurement of nebulizer sprays: a quantitative comparison of diffraction, phase doppler interferometry, and time of flight techniques. J Aerosol Sci 2000;31:35-50
   Web of Science ®Google Scholar
• Stapleton KW, Finlay WH, Zuberbuhler P. An in vitro method for measuring regional dosages delivered by jet nebulizers. J Aerosol Med 1994;7:325-44
   PubMedGoogle Scholar
• Clark AR. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 1995;115:69-78
   Web of Science ®Google Scholar
• Lelong N, Junqua-Moullet A, Diot P, Vecellio L. Comparison of laser diffraction measurements by mastersizer X and spraytec to characterize droplet size distribution of medical liquid aerosols. J Aerosol Med 2014;27:94-102
   Google Scholar
• Amirav I, Borojeni AA, Halamish A, et al. Nasal versus oral aerosol delivery to the "lungs" in infants and toddlers. Pediatr Pulmonol 2014. 10.1002/ppul.22999
   PubMed Web of Science ®Google Scholar
• Georgitis JW, McWilliams B, Cruz-Rivera M, et al. Effective once-daily administration of budesonide inhalation suspension by nebulizer with facemasks or mouthpieces for persistent asthma in infants and young children. Pediatr Asthma Allergy Immunol 2001;15:3-13
   Google Scholar
• Kishida M, Suzuki I, Kabayama H, et al. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma. J Asthma 2002;39:337-9
   PubMed Web of Science ®Google Scholar
• Mellon M, Leflein J, Walton-Bowen K, et al. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000;162:593-8
   PubMed Web of Science ®Google Scholar
• Boe J, Dennis JH, O’Driscoll BR. European respiratory society guidelines on the use of nebulisers. Eur Respir J 2001;18:228-42
   PubMed Web of Science ®Google Scholar
• Harris KW, Smaldone GC. Facial and ocular deposition of nebulized budesonide - Effects of face mask design. Chest 2008;133:482-8
   PubMed Web of Science ®Google Scholar
• Sangwan S, Gurses BK, Smaldone GC. Facemasks and facial deposition of aerosols. Pediatr Pulmonol 2004;37:447-52
   PubMed Web of Science ®Google Scholar
• Amirav I, Balanov I, Gorenberg M, et al. Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!. Arch Dis Child 2003;88:719-23
   PubMed Web of Science ®Google Scholar
• Amirav I, Oron A, Tal G, et al. Aerosol delivery in respiratory syncytial virus bronchiolitis: hood or face mask? J Pediatr 2005;147:627-31
   PubMed Web of Science ®Google Scholar
• Kim J, Xi J, Si X, et al. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model. J Aerosol Med Pulm Drug Deliv 2014;27:209-18
   PubMed Web of Science ®Google Scholar
• Kugelman A, Amirav I, Mor F, et al. Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit. J Perinatol 2006;26:31-6
   PubMed Web of Science ®Google Scholar
• Finlay WH, Stapleton KW, Zuberbuhler P. Variations in predicted regional lung deposition of salbutamol sulphate between 19 nebulizer types. J Aerosol Med 1998;11:65-80
   Google Scholar
• CEN. Respiratory therapy equipment - Part 1: nebulizing systems and their components
   Google Scholar
• ISO. Anaesthetic and respiratory equipment - Nebulizing systems and components
   Google Scholar
• Rodrigo GJ, Pollack CV, Rodrigo C, Rowe BH. Heliox for non-intubated acute asthma patients. Cochrane Database Syst Rev 2006(4):CD002884
   Google Scholar
• Anderson M, Svartengren M, Bylin G, et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis 1993;147:524-8
   PubMed Web of Science ®Google Scholar
• Corcoran TE, Shortall BP, Kim IK, et al. Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model. J Aerosol Med 2003;16:263-71
   PubMedGoogle Scholar
• Darquenne C, Prisk GK. Aerosol deposition in the human respiratory tract breathing air and 80:20 heliox. J Aerosol Med 2004;17:278-85
   PubMedGoogle Scholar
• Katz I, Pichelin M, Montesantos S, et al. Using helium-oxygen to improve regional deposition of inhaled particles: mechanical principles. J Aerosol Med Pulm Drug Deliv 2014;27:71-80
   PubMed Web of Science ®Google Scholar
• Kim IK, Saville AL, Sikes KL, Corcoran TE. Heliox-driven albuterol nebulization for asthma exacerbations: an overview. Respir Care 2006;51:613-18
   PubMed Web of Science ®Google Scholar
• Corcoran TE, Gamard S. Development of aerosol drug delivery with helium oxygen gas mixtures. J Aerosol Med 2004;17:299-309
   PubMedGoogle Scholar
• Fink JB. Opportunities and risks of using heliox in your clinical practice. Respir Care 2006;51:651-60
   PubMed Web of Science ®Google Scholar
• Martin AR, Gleske J, Katz IM, et al. Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium-oxygen mixture. J Aerosol Sci 2010;41:1159-66
   Web of Science ®Google Scholar
• O’Callaghan C, White J, Jackson J, et al. The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers. J Aerosol Med 2007;20:434-44
   PubMedGoogle Scholar
• Holland A, Smith F, Penny K, et al. Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units. Cochrane Database Syst Rev 2013;6:CD008863
   Google Scholar
• Montgomery AB, Vallance S, Abuan T, et al. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the pari investigational eflow inline nebulizer system in mechanically ventilated patients. J Aerosol Med Pulm Drug Deliv 2014;27(6):441-48
   PubMed Web of Science ®Google Scholar
• Lu Q, Luo R, Bodin L, et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii. Anesthesiology 2012;117:1335-47
   PubMed Web of Science ®Google Scholar
• Wood G. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Expert Rev Anti Infect Ther 2011;9:993-1000
   PubMed Web of Science ®Google Scholar
• Abu-Salah T, Dhand R. Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update. Adv Ther 2011;28:728-47
   PubMed Web of Science ®Google Scholar
• Lu Q, Yang J, Liu Z, et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by pseudomonas aeruginosa. Am J Respir Crit Care Med 2011;184:106-15
   PubMed Web of Science ®Google Scholar
• Beaty CD, Ritz RH, Benson MS. Continuous in-line nebulizers complicate pressure support ventilation. Chest 1989;96:1360-3
   PubMed Web of Science ®Google Scholar
• Miller DD, Amin MM, Palmer LB, et al. Aerosol delivery and modern mechanical ventilation - In vitro/in vivo evaluation. Am J Respir Crit Care Med 2003;168:1205-9
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB, Dhand R. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012;25:319-32
   PubMed Web of Science ®Google Scholar
• Odoherty MJ, Thomas SH. Nebuliser therapy in the intensive care unit. Thorax 1997;52:S56-9
   Google Scholar
• Odoherty MJ, Thomas SH, Page CJ, et al. Delivery of a nebulized aerosol to a lung model during mechanical ventilation - effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis 1992;146:383-8
   PubMed Web of Science ®Google Scholar
• Hughes JM, Saez J. Effects of nebulizer mode and position in mechanical ventilator circuit on dose efficiency. Respir Care 1987;32:1131-5
   Google Scholar
• Ari A, Areabi H, Fink JB. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 2010;55:837-44
   PubMed Web of Science ®Google Scholar
• Oriordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients - optimizing nebulizer delivery. Am J Respir Crit Care Med 1994;149:214-19
   PubMed Web of Science ®Google Scholar
• Oriordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992;145:1117-22
   PubMed Web of Science ®Google Scholar
• Harvey CJ, Odoherty MJ, Page CJ, et al. Effect of a spacer on pulmonary aerosol deposition from a jet nebulizer during mechanical ventilation. Thorax 1995;50:50-3
   PubMed Web of Science ®Google Scholar
• Thomas SH, Odoherty MJ, Fidler HM, et al. Pulmonary deposition of a nebulized aerosol during mechanical ventilation. Thorax 1993;48:154-9
   PubMed Web of Science ®Google Scholar
• Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal-tubes. Pediatr Pulmonol 1986;2:19-26
   PubMed Web of Science ®Google Scholar
• Martin AR, Ang A, Katz IM, et al. An in vitro assessment of aerosol delivery through patient breathing circuits used with medical air or a helium-oxygen mixture. J Aerosol Med Pulm Drug Deliv 2011;24:225-34
   PubMed Web of Science ®Google Scholar
• Ari A, Atalay OT, Harwood R, et al. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55:845-51
   PubMed Web of Science ®Google Scholar
• Dubus JC, Vecellio L, De Monte M, et al. Aerosol deposition in neonatal ventilation. Pediatr Res 2005;58:10-14
   PubMed Web of Science ®Google Scholar
• Berlinski A, Willis RJ. Albuterol delivery by 4 different nebulizers placed in different positions in a pediatric ventilator in vitro model. Respir Care 2013;58:1124-33
   PubMed Web of Science ®Google Scholar
• Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 2012;25:63-78
   PubMed Web of Science ®Google Scholar
• Galindo-Filho VC, Brandao DC, Ferreira Rde C, et al. Noninvasive ventilation coupled with nebulization during asthma crises: a randomized controlled trial. Respir Care 2013;58:241-9
   PubMed Web of Science ®Google Scholar
• Dai B, Kang J, Sun LF, et al. Influence of exhalation valve and nebulizer position on albuterol delivery during noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 2014;27:125-32
   PubMed Web of Science ®Google Scholar
• White CC, Crotwell DN, Shen S, et al. Bronchodilator delivery during simulated pediatric noninvasive ventilation. Respir Care 2013;58:1459-66
   PubMed Web of Science ®Google Scholar
• Abdelrahim M, Plant P, Chrystyn H. The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. Int J Pharm 2011;420:313-18
   PubMed Web of Science ®Google Scholar
• Abdelrahim ME, Plant P, Chrystyn H. In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62:966-72
   PubMed Web of Science ®Google Scholar
• Melani AS, Canessa P, Coloretti I, et al. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use. Respir Med 2012;106:668-76
   PubMed Web of Science ®Google Scholar
• ODonohue WJ, Baker JP, Dexter JR, et al. Guidelines for the use of nebulizers in the home and at domiciliary sites - Report of a consensus conference. Chest 1996;109:814-20
   PubMed Web of Science ®Google Scholar
• Cipolla D, Chan HK. Inhaled antibiotics to treat lung infection. Pharm Pat Anal 2013;2:647-63
   PubMedGoogle Scholar
• Rottier BL, van Erp CJ, Sluyter TS, et al. Changes in performance of the pari eflow (R) rapid and pari LC plus (TM) during 6 months use by CF patients. J Aerosol Med Pulm Drug Deliv 2009;22:263-9
   PubMed Web of Science ®Google Scholar
• Denyer J, Black A, Nikander K, et al. Domiciliary experience of the target inhalation mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv 2010;23:S45-54
   PubMed Web of Science ®Google Scholar
• Denyer J, Dyche T. The adaptive aerosol delivery (AAD) technology: past, present, and future. J Aerosol Med Pulm Drug Deliv 2010;23:S1-S10
   PubMed Web of Science ®Google Scholar
• Fischer A, Stegemann J, Scheuch G, Siekmeier R. Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials. Eur J Med Res 2009;14(Suppl 4):71-7
   PubMedGoogle Scholar
• Scheuch G, Siekmeier R. Novel approaches to enhance pulmonary delivery of proteins and peptides. J Physiol Pharmacol 2007;58:615-25
   PubMed Web of Science ®Google Scholar
• Denyer J, Nikander K, Smith NJ. Adaptive aerosol delivery (AAD) technology. Expert Opin Drug Deliv 2004;1:165-76
   PubMedGoogle Scholar
• Dalby R, Spallek M, Voshaar T. A review of the development of Respimat((R)) Soft Mist (TM) Inhaler. Int J Pharm 2004;283:1-9
   PubMed Web of Science ®Google Scholar
• Hochrainer D, Holz H, Kreher C, et al. Comparison of the aerosol velocity and spray duration of Respimat (R) Soft Mist (TM) Inhaler and pressurized metered dose inhalers. J Aerosol Med 2005;18:273-82
   PubMedGoogle Scholar
• Wise RA, Anzueto A, Cotton D, et al. Tiotropium respimat inhaler and the risk of death in COPD. N Engl J Med 2013;369:1491-501
   PubMed Web of Science ®Google Scholar
• Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat soft mist inhaler. Int J Chron Obstruct Pulmon Dis 2009;4:381-90
   PubMedGoogle Scholar
• Geller DE. The science of aerosol delivery in cystic fibrosis. Pediatr Pulmonol 2008;43:S5-S17
   Web of Science ®Google Scholar
• O’Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax 1997;52:S32-44
   Google Scholar